Published 2002 | Version v1
Journal article

The antibiotic peptide 99'MTc-alafosfalin detects inflamed bowel in rats

  • 1. Royal Adelaide Hospital, SA (Australia). RAH Radiopharmacy, Nuclear Medicine Department

Description

Full text: Radiolabelled leucocyte scans are established as an accurate method of detecting inflammatory bowel disease and focal infection but involve complex in vitro cell labelling techniques. As antibiotic peptides accumulate at sites of inflammation, we studied the localisation of the antibiotic dipeptide 99mTc-alafosfalin in a rat model of colitis and compared it to the non-specific marker 99mTc-DTPA. Distal colitis was induced in female Sprague-Dawley rats (175g) 4 days following the rectal infusion of 1 ml trinitrobenzylsulphonic acid (80mg/ml; 30% aq. ethanol). Six colitic and 6 control rats were each injected intravenously with 5MBq 99mTc-alafosfalin (>90% radiolabelling efficiency) and 5MBq 99mTc-DTPA and organ and target site uptake measured by scintigraphy and quantitative counting of excised tissue (% injected dose/gram tissue) at 1 and 4 hours. Colitis was confirmed by histological examination of rectal specimens. The scans and tissue counts showed significant focal accumulation of 99mTc-alafosfalin in inflamed rectum compared to normal bowel (p<0.05). There was a sustained increase in the ratio of uptake in the inflamed to non- inflamed bowel at 1 and 4 hours (mean + S.E.) with 99mTc-alafosfalin compared to 99mTc-DTPA (p=0.03). Copyright (2002) The Australian and New Zealand Society of Nuclear Medicine Inc

Availability note (English)

Available in abstract form only, full text entered in this record

Additional details

Publishing Information

Journal Title
ANZ Nuclear Medicine
Journal Volume
33
Journal Issue
suppl
Journal Page Range
p. 37
ISSN
1324-1435

Conference

Title
32. Annual Scientific Meeting of the Australian and New Zealand Society of Nuclear Medicine
Dates
4-8 May 2002
Place
Cairns, QLD (Australia)

Optional Information

Notes
1 tabs.